retatrutide addiction treatment Is a new weight-loss drug making people fall out of love? | Weight-loss drugs Retatrutide vs Tirzepatide — What

Based on Phase 2 trial data (Jastreboff et al., NEJM 2023), injection site reactions with retatrutide were among the more commonly reported adverse events, occurring across multiple dose groups

No long waits or sitting around a doctors office

The SURMOUNT-1 study reported dose-dependent triglyceride reductions of 15-25% with the highest doses (10-15 mg weekly), alongside LDL cholesterol decreases of 6-10%

All treatments require evaluation and guidance from a licensed healthcare provider

See the full breakdown at BPC-157 dosage for a 200 lb male

Emerging therapies, such as Tirzepatide, a dual GLP-1/GIP agonist, and Orforglipron, a nonpeptide oral GLP-1 RA, continue to expand the potential of this medication class in treating metabolic diseases (23)(24)